GR1004193B - Pharmaceutical composition containing citalopram - Google Patents

Pharmaceutical composition containing citalopram

Info

Publication number
GR1004193B
GR1004193B GR20010100377A GR2001100377A GR1004193B GR 1004193 B GR1004193 B GR 1004193B GR 20010100377 A GR20010100377 A GR 20010100377A GR 2001100377 A GR2001100377 A GR 2001100377A GR 1004193 B GR1004193 B GR 1004193B
Authority
GR
Greece
Prior art keywords
citalopram
pharmaceutical composition
composition containing
containing citalopram
mixture
Prior art date
Application number
GR20010100377A
Other languages
Greek (el)
Other versions
GR20010100377A (en
Inventor
Per Holm
Ken Liljegren
Ole Nielsen
Swen Wagner
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR1004193(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of GR20010100377A publication Critical patent/GR20010100377A/en
Publication of GR1004193B publication Critical patent/GR1004193B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Abstract

solid unit dosage form comprising citalopram, which is prepared by direct compression of a mixture of citalopram base or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable excipients, or by filling of said mixture in a hardgelatine capsule. Large crystals of a pharmaceutical acceptable salt of citalopram and method for the manufacture of said large crystals.
GR20010100377A 2000-08-10 2001-07-31 Pharmaceutical composition containing citalopram GR1004193B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
GR20010100377A GR20010100377A (en) 2002-09-06
GR1004193B true GR1004193B (en) 2003-03-24

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100377A GR1004193B (en) 2000-08-10 2001-07-31 Pharmaceutical composition containing citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (en)
JP (1) JP2003531153A (en)
KR (1) KR20030024833A (en)
CN (1) CN1446089A (en)
AR (1) AR030095A1 (en)
AT (1) AT5744U1 (en)
AU (2) AU2001100198B4 (en)
BE (1) BE1013559A6 (en)
BG (1) BG107578A (en)
BR (1) BR0113250A (en)
CA (1) CA2353693C (en)
CH (2) CH694241A5 (en)
CZ (1) CZ2003397A3 (en)
DE (2) DE20113195U1 (en)
EA (1) EA200300247A1 (en)
ES (1) ES2172481B2 (en)
FI (1) FI5176U1 (en)
FR (1) FR2812811B1 (en)
GB (1) GB2368014B (en)
GR (1) GR1004193B (en)
HR (1) HRP20030054A2 (en)
HU (1) HUP0103071A3 (en)
IE (1) IES20010693A2 (en)
IL (1) IL154050A0 (en)
IS (1) IS6021A (en)
IT (1) ITMI20011637A1 (en)
MX (1) MXPA03000837A (en)
NL (1) NL1018741C1 (en)
NO (1) NO20013891L (en)
NZ (1) NZ523785A (en)
PL (1) PL359824A1 (en)
SK (1) SK2842003A3 (en)
WO (1) WO2001080619A2 (en)
YU (1) YU9003A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
ATE388947T1 (en) * 2002-12-23 2008-03-15 Lundbeck & Co As H ESCITALOPRAM HYDROBROMIDE AND A METHOD FOR THE PRODUCTION THEREOF
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (en) * 2006-01-05 2007-12-12 昆明积大制药有限公司 Antidepressant composition containing citalopram and cyclodextrin
GB2480191A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
WO2017020841A1 (en) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 Pharmaceutical composition containing lcz696 and preparation method thereof
WO2022153262A1 (en) * 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug response by a serotonin 1A receptor antagonist
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
NO20013891L (en) 2002-02-11
YU9003A (en) 2006-05-25
IES20010693A2 (en) 2002-07-10
NO20013891D0 (en) 2001-08-09
AT5744U1 (en) 2002-11-25
CZ2003397A3 (en) 2003-06-18
JP2003531153A (en) 2003-10-21
CA2353693C (en) 2003-07-22
FR2812811B1 (en) 2006-08-18
BG107578A (en) 2003-09-30
ES2172481B2 (en) 2004-08-01
CH694241A5 (en) 2004-10-15
NZ523785A (en) 2004-09-24
HU0103071D0 (en) 2001-10-28
IL154050A0 (en) 2003-07-31
AU2001279591A1 (en) 2001-11-07
DE10139115A1 (en) 2002-03-28
GB2368014A (en) 2002-04-24
ITMI20011637A0 (en) 2001-07-27
SK2842003A3 (en) 2003-09-11
WO2001080619A2 (en) 2001-11-01
AR030095A1 (en) 2003-08-13
CN1446089A (en) 2003-10-01
GR20010100377A (en) 2002-09-06
AU2001100198B4 (en) 2002-06-13
ITMI20011637A1 (en) 2003-01-27
CA2353693A1 (en) 2002-01-22
WO2001080619A3 (en) 2002-02-21
HUP0103071A3 (en) 2002-12-28
IS6021A (en) 2001-10-20
FR2812811A1 (en) 2002-02-15
BR0113250A (en) 2003-06-24
ES2172481A1 (en) 2002-09-16
FI5176U1 (en) 2001-12-27
BE1013559A6 (en) 2002-03-05
EA200300247A1 (en) 2003-06-26
HRP20030054A2 (en) 2005-02-28
GB2368014B (en) 2004-06-23
HUP0103071A2 (en) 2002-05-29
GB0118579D0 (en) 2001-09-19
KR20030024833A (en) 2003-03-26
EP1318805A2 (en) 2003-06-18
AU2001100198A4 (en) 2001-08-16
MXPA03000837A (en) 2003-06-06
NL1018741C1 (en) 2002-02-12
CH694242A5 (en) 2004-10-15
DE20113195U1 (en) 2001-11-15
PL359824A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
DE69620606D1 (en) FIXED ORAL APPLICATION FORM
DK1117383T3 (en) Dosage forms comprising therapeutic formulation
YU21999A (en) Pharmaceutical compositions and procedure for the production thereof
UA41346C2 (en) Pharmaceutical composition containing fluoxetin or its salt, tablet based on composition thereof, method for manufacturing dispersed tablets
GR1004193B (en) Pharmaceutical composition containing citalopram
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
AP2003002763A0 (en) Controlled release formulations for oral administration
TWI264311B (en) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
TW200509905A (en) Pharmaceutical compositions of atorvastatin
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
IL150528A0 (en) Ibuprofen containing active agent preparation
MXPA03011317A (en) Swallow tablet comprising paracetamol.
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
TW200517127A (en) Novel composition
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
YU54503A (en) Pharmaceutical composition containing citalopram
TW200500085A (en) Sustained-release pharmaceutical composition for lung administration
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
PL1499278T3 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
MY145885A (en) Controlled release formulations for oral administration
RU96111879A (en) METHOD FOR PREPARING HOMEOPATHIC SOFT MEDICAL FORMS